View a Chinese translation of this page.–>
Gut is a leading international journal in gastroenterology and hepatology and has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage in all areas of gastroenterology and hepatology. Regular features include articles describing novel mechanisms of disease and new management strategies, both diagnostic and therapeutic, likely to impact on clinical practice within the foreseeable future by leading authorities.
Gut will consider very high quality papers under the Fast Track Review scheme. This scheme relies on a dedicated group of top class reviewers to deliver a final decision on reviewed manuscripts within seven days. The scheme is free to authors; the journal donates money to charity for every completed manuscript.
BMJ fully supports and encourages the archiving of preprints in any recognised, not-for-profit server such as medRxiv. BMJ does not consider the posting of an article in a dedicated preprint repository to be prior publication.
Frontline Gastroenterology is the education and practice companion journal to Gut. It is indexed by Web of Science Core Collection: Emerging Sources Citation Index; PubMed Central; Embase (Excerpta Medica); CINAHL; Google Scholar, and covers the fields of gastroenterology, hepatology and clinical nutrition. The journal publishes articles in the domains of clinical quality, patient experience, service provision and medical education. Find out more about Frontline Gastroenterology.
Please note that the article transfer service does not guarantee acceptance but you should receive a quicker initial decision on your manuscript.Contact the Transfer Editor at firstname.lastname@example.org
If authors choose to publish their article open access, an APC waiver may be available. Before applying for an APC waiver please consider:
(1) Does your institution have an open access agreement with BMJ? If it does, then this may cover all or part of the APC for your article. Check BMJ’s open access agreements page to find out whether your institution is a member and what discounts you may be entitled to.
(2) Have you received funding from a funder with an open access mandate or policy that covers paying APCs? If so, BMJ expects that the APC will be paid in full.
If neither (1) nor (2) above apply then consider
(3) Are all the authors of your article based in low-income countries*? If so, you are eligible to apply for a full or partial waiver from BMJ.
Visit our author hub to learn more about our waivers policy and how to request one.
Please note that regardless of the funding situation, authors can still choose to publish with us at no cost, and articles will be made available to our subscribers.
*This list is reviewed annually and is based upon HINARI Core Offer Groups A and B, and the World Bank Country and Lending Groups.
Please find more information about ORCID and BMJ’s policy on our Author Hub.
We appreciate that patient and public involvement is relatively new and may not be feasible or appropriate for all papers. We therefore continue to consider papers where patients were not involved.
The Patient and Public Involvement statement should provide a brief response to the following questions, tailored as appropriate for the study design reported (please find example statements here):
- At what stage in the research process were patients/the public first involved in the research and how?
- How were the research question(s) and outcome measures developed and informed by their priorities, experience, and preferences?
- How were patients/the public involved in the design of this study?
- How were they involved in the recruitment to and conduct of the study?
- Were they asked to assess the burden of the intervention and time required to participate in the research?
- How were (or will) they be involved in your plans to disseminate the study results to participants and relevant wider patient communities (e.g. by choosing what information/results to share, when, and in what format)?
If patients were not involved please state this.
In addition to considering the points above we advise authors to look at guidance for best reporting of patient and public involvement as set out in the GRIPP2 reporting checklist.
If the Patient and Public Involvement statement is missing in the submitted manuscript we will request that authors provide it.
For further support when making your submission please refer to the resources available on the BMJ Author Hub. Here you will find information on writing and formatting your research through to the peer review process and promoting your paper. You may also wish to use the language editing and translation services provided by BMJ Author Services.
If your article is accepted, visit our “Promoting Your Paper” page on the BMJ Author Hub for suggestions on how to maximise your article’s reach.
Following the lead of The BMJ and its patient partnership strategy, Gut is encouraging active patient involvement in setting the research agenda. As such, we require authors of Research Articles to add a Patient and Public Involvement statement in the Methods section.
Structured abstract: up to 250 words: ‘Objective’, ‘Design’, ‘Results’, ‘Conclusion’
Tables/ Illustrations: Figures are not limited, but must be thoroughly justified.
References: limited to those critical and relevant to the manuscript (around 50)
Please include the key messages of your article after your abstract using the following headings. This section should be no more than 3-5 sentences and should be distinct from the abstract; be succinct, specific and accurate.
- What is already known on this topic – summarise the state of scientific knowledge on this subject before you did your study and why this study needed to be done
- What this study adds – summarise what we now know as a result of this study that we did not know before
- How this study might affect research, practice or policy – summarise the implications of this study
This will be published as a summary box after the abstract in the final published article.
- Introduction - a brief clinical introduction to a case (maximum 200 words) followed by an image and a question designed to stimulate the reader to think about what the image shows. The legend should not indicate the diagnosis but should simply describe the nature of the image (e.g. 'endoscopic view of second part of duodenum').
- Answer - appears later in the issue (maximum 200 words) outlines a brief description of the key diagnostic features of the image, the outcome, and a teaching point. GI snapshots will not include more than 5 references.
- The journal editor, an editorial board member or a learned society may wish to organise a meeting, sponsorship may be sought and the proceedings published as a supplement.
- The journal editor, editorial board member or learned society may wish to commission a supplement on a particular theme or topic. Again, sponsorship may be sought.
- The BMJPG itself may have proposals for supplements where sponsorship may be necessary.
- A sponsoring organisation, often a pharmaceutical company or a charitable foundation, that wishes to arrange a meeting, the proceedings of which will be published as a supplement.
- Journal in which you would like the supplement published
- Title of supplement and/or meeting on which it is based
- Date of meeting on which it is based
- Proposed table of contents with provisional article titles and proposed authors
- An indication of whether authors have agreed to participate
- Sponsor information including any relevant deadlines
- An indication of the expected length of each paper Guest Editor proposals if appropriate